[1]
S. Khaidarov, “Targeted in vitro- confirmation of the antiviral activity of Tenvir (Tenofovir) drug against the SARS-COV-2 virus variant B. in Kazakhstan and identifying NSP12 in the viral genome”, Eurasian Journal of Applied Biotechnology, no. 2, pp. 49–60, Jul. 2024.